Loading candles…
Onyx Biotech Ltd, incorporated in 2005, operates in the pharmaceutical formulations industry with a focus on the parenteral (injectable) pharmaceutical segment. The company manufactures and markets sterile water for injections, dry powder injections, and dry syrup primarily through a business-to-business model. It also functions as a contract manufacturer for several prominent pharmaceutical firms. Onyx Biotech's operations are centered in Baddi, Himachal Pradesh, India, and it serves customers both within India and overseas. The company does not have listed subsidiaries or ventures, nor is it listed on any stock exchanges.
This page is a live market overview for ONYX BIOTEC LIMITED (ONYX) on the NSE. As a listed security, ONYX BIOTEC LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for ONYX before placing trades on tick2trade.
As of the latest feed, ONYX last traded at ₹37 on NSE, up ₹0 (0.00%) from the previous close of ₹37. Today's session range is ₹0 – ₹0, against a 52-week band of ₹0 – ₹50. Traded volume today stands at — shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for ONYX in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether ONYX is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for ONYX BIOTEC LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in ONYX. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated ONYX option chain page linked from this overview.
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.